Flowchart of inclusion of patients. by Fatma Karapinar-Çarkıt (3956189)

Cost-effectiveness analyses for drug-related rehospitalisations. by Fatma Karapinar-Çarkıt (3956189)

Cost-effectiveness analyses for unplanned rehospitalisations. by Fatma Karapinar-Çarkıt (3956189)

Patient characteristics for usual care and the COACH program. by Fatma Karapinar-Çarkıt (3956189)

Results of adjusted cost-effectiveness and cost-utility analyses. by Fatma Karapinar-Çarkıt (3956189)

Costs used in the economic evaluation, corrected for the year 2011. by Fatma Karapinar-Çarkıt (3956189)

Pooled total effects and costs and differences in total effects and costs during follow-up. by Fatma Karapinar-Çarkıt (3956189)

Usual care and COACH program components and the timeline plus measured outcomes. by Fatma Karapinar-Çarkıt (3956189)

BmVg interacts with SWP12, SWP26 and SWP30. by Chunxia Wang (766713)

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”

Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line by Kevin Hollevoet (710450)

“…Bisulfite sequencing analysis found that the mesothelin promoter region was significantly more methylated in KLM-1-R (59 ± 3.6%) compared to KLM-1 (41 ± 4.8%), indicating hypermethylation as a mechanism of mesothelin downregulation. The DNA methyltransferase inhibitor 5-azacytidine restored original mesothelin surface expression to more than half in KLM-1-R and increased sensitivity to RG7787 (IC₅₀ = 722.4 ± 232.6 ng/ml), although cells remained significantly less sensitive compared to parental KLM-1 cells (IC₅₀ = 4.41 ± 0.38 ng/ml). …”

TET1 regulates the mRNA and protein expression of TNFα. by Fangfang Sun (2410654)

Supplemental Figure 9 from BRAF Inhibition Decreases Cellular Glucose Uptake in Melanoma in Association with Reduction in Cell Volume by Nicholas Theodosakis (3466673)

Total number of identified bone proteins with differences in abundance in each comparison, by label-free semi-quantitative differential expression analysis. by Cláudia A. N. Kobayashi (673416)

Categorization of NIAMS grants, funding, and US Global Burden of Disease DALY metrics (arranged in order of decreasing US DALY). by Chante Karimkhani (594512)

ST2+ KLRG-1+ Tregs from <i>T</i>. <i>cruzi</i> infected mice exhibit a phenotype compatible with <i>bona fide</i> trTregs. by Santiago Boccardo (5927954)

AMPK depletion is associated with decreased association of OGT with proteasome and increased 26S proteasome assembly and activity in AMPK-KO mice. by Jian Xu (31545)

Knock down of <i>edin</i> in the fat body decreases the encapsulation and killing ability of <i>Drosophila</i> larvae. by Leena-Maija Vanha-aho (323292)

“…Data are pooled from three to sixteen independent experiments, as indicated on each column, and at least 50 infected larvae were scored per experiment. Error bars in A and B show standard deviations. …”

THP1 TET1 knockout cell line was generated using CRISPR/Cas9. by Fangfang Sun (2410654)

Dose-dependence and time-dependence of peptides that showed partial decreases (left panels) and increases (right panels) in response to bortezomib. by Julia S. Gelman (104378)

“…Peptides that partially decreased (ratio 0.2 to 0.8, n = 26) or partially increased (ratio 1.25 to 4.0, n = 50) in the 500 nM data set were compared to the same peptides observed in the 50 nM data set. …”